Sign Up For Updates

Join us for a live virtual educational event—an opportunity to connect with other hereditary angioedema (HAE) patients and learn about the ANDEMBRY difference.

Upcoming Events

RegisterProgramEvent LinkSpeakers
RegisterANDEMBRY® (garadacimab-gxii) Patient Education Event
Thursday, September 24 2026, 7:30 PM – 8:30 PM EDT		https://andembrypatienteducation.com/registration/events/4041Donald S. Levy, MD
RegisterANDEMBRY® (garadacimab-gxii) Patient Education Event
Wednesday, October 21 2026, 8:00 PM – 9:00 PM EDT		https://andembrypatienteducation.com/registration/events/4023Raffi Tachdjian, MD, MPH
RegisterANDEMBRY® (garadacimab-gxii) Patient Education Event
Wednesday, November 18 2026, 8:30 PM – 9:30 PM EDT		https://andembrypatienteducation.com/registration/events/4042Priya J. Bansal, MD
RegisterANDEMBRY® (garadacimab-gxii) Patient Education Event
Thursday, December 10 2026, 7:00 PM – 8:00 PM EDT		https://andembrypatienteducation.com/registration/events/4043Cristine Radojicic, MD

About the Programs

These educational programs given by a
healthcare professional offer you and your loved ones the opportunity to:

  • Learn about a once-monthly prophylactic HAE treatment option delivered in ≤15 seconds via an autoinjector
  • Discover how you or your loved one may experience sustained protection from HAE attacks, starting at week 1
  • Hear from a Patient Advocate* who will share their experience living with HAE and taking ANDEMBRY
  • Connect, ask questions, and find support from others in the HAE community

* Advocates are not healthcare providers or medical experts and are compensated for their participation. For medical questions, you should contact your physician

Important Safety Information

What are the possible side effects of ANDEMBRY?

The most common side effects of ANDEMBRY include:

  • Redness, itchiness, and bruising (injection-site reactions)
  • Stomach (abdominal) pain
  • Runny or stuffy nose, sneezing, watery eyes (nasopharyngitis)

What is ANDEMBRY?

ANDEMBRY® (garadacimab-gxii) injection, for subcutaneous use, is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 12 years and older.

It is not known if ANDEMBRY is safe and effective in children under 12 years of age.

What should I tell my healthcare provider before using ANDEMBRY?

Before using ANDEMBRY, tell your healthcare provider about any medical condition you may have, especially if you are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed. It is not known if ANDEMBRY can harm your unborn baby or if ANDEMBRY passes into breastmilk. Talk to your healthcare provider about the best way to feed your baby while using ANDEMBRY.

Tell your healthcare provider about all medications you take, including prescription medicines, over-the-counter treatments, vitamins, and herbal supplements.

How should I use ANDEMBRY?

Use ANDEMBRY exactly as instructed by your healthcare provider. Detailed instructions for use can be found in the patient information section of the full prescribing information.

ANDEMBRY is given as an injection under your skin (subcutaneous) by you or a caregiver. Your healthcare provider should show you or your caregiver how to prepare and inject your dose of ANDEMBRY before you inject yourself for the first time. Do not try to inject ANDEMBRY unless you have been trained by your healthcare provider.


Please see full prescribing information for ANDEMBRY, including patient information and instructions for use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You can also report side effects to CSL Behring’s Pharmacovigilance Department at 1-866-915-6958.

ANDEMBRY is manufactured by CSL Behring GmbH and distributed by CSL Behring LLC.
ANDEMBRY® is a registered trademark of CSL Behring GmbH.
ANDEMBRY ConnectSM is a service mark of CSL Behring LLC.
©2026 CSL Behring LLC. The product information presented on this site is intended for US residents only. USA-AND-0110-JUL26
www.ANDEMBRY.com

Important Safety Information

What are the possible side effects of ANDEMBRY?

The most common side effects of ANDEMBRY include:

What is ANDEMBRY?

ANDEMBRY® (garadacimab-gxii) injection, for subcutaneous use, is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 12 years and older.

It is not known if ANDEMBRY is safe and effective in children under 12 years of age.

What should I tell my healthcare provider before using ANDEMBRY?

Before using ANDEMBRY, tell your healthcare provider about any medical condition you may have, especially if you are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed. It is not known if ANDEMBRY can harm your unborn baby or if ANDEMBRY passes into breastmilk. Talk to your healthcare provider about the best way to feed your baby while using ANDEMBRY.

Tell your healthcare provider about all medications you take, including prescription medicines, over-the-counter treatments, vitamins, and herbal supplements.

How should I use ANDEMBRY?

Use ANDEMBRY exactly as instructed by your healthcare provider. Detailed instructions for use can be found in the patient information section of the full prescribing information.

ANDEMBRY is given as an injection under your skin (subcutaneous) by you or a caregiver. Your healthcare provider should show you or your caregiver how to prepare and inject your dose of ANDEMBRY before you inject yourself for the first time. Do not try to inject ANDEMBRY unless you have been trained by your healthcare provider.


Please see full prescribing information for ANDEMBRY, including patient information and instructions for use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You can also report side effects to CSL Behring’s Pharmacovigilance Department at 1-866-915-6958.